Drugs and Devices

FDA approves Tivicay for HIV infection

On August 12, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares